Unlearn.AI is a technology company that is developing a platform to help pharmaceutical companies accelerate clinical trials and bring new treatments to market faster. The company's platform uses artificial intelligence to create digital twins of patients, which can be used to simulate the effects of different treatments and predict how patients will respond to them. Unlearn.AI's technology has the potential to reduce the time and cost of clinical trials, and improve the accuracy of drug development.